New healthcare technologies are set to be tested together with the general public healthcare clusters in Singapore for potential future adoption and large-scale implementation.
A complete of SG$2.4 million ($1.7 million) in funding has been awarded to six near-market-ready solutions in the recent Healthcare InnoMatch 2022 organised by the Centre for Healthcare Innovation and supported by the Ministry of Health insurance and Temasek Foundation.
Launched this past year, Healthcare InnoMatch can be an annual challenge gathering technology proposals from startups and small and medium enterprises for solving the pressing healthcare challenges and transforming the continuing future of healthcare. For the very first time in its second year, the function saw all three public healthcare clusters in Singapore National Healthcare Group (NHG), National University Health System (NUHS) and Singapore Health Services (SingHealth) interact to measure the feasibility of proposed projects.
WHAT IT’S ABOUT
The next six projects bested a lot more than 250 applications all over the world:
- PreSAGE by CoNEX Healthcare (partnered with NHG) – AI-powered image-based solution for predicting and preventing falls in hospitals, assisted living facilities and residential homes.
- FxMammo by FathomX (partnered with NUHS) – AI support tool for analysing mammograms in the first detection of breast cancer.
- KIMIA Recovery Management System by Kinexcs (partnered with SingHealth) – post-surgical recovery management solution for remote tabs on a patient’s joint condition. It includes a smart wearable sensor device and an AI digital therapist that guides users in exercise and detects complications post-surgery.
- NuCalm (partnered with SingHealth) – neuroscience-based technology that’s clinically which can reduce stress and improve sleep quality.
- QTX Magnetic Mitohormesis by QuantumTX (partnered with NUHS) – muscle-mitochondria activating technology that delivers supplementary muscle activation to boost post-stroke recovery and functional independence.
- Us2.AI (partnered with NHG and SingHealth) – automated cardiac ultrasound software for the diagnosis of heart failure.
WHY IT MATTERS
The six winners have already been paired with a minumum of one public healthcare cluster where they are able to further customise their offerings and gain feedback from providers and patients. The partnership is made to accelerate the development of these near market-ready technologies and prepare them for large-scale implementation and commercialisation in Singapore and beyond.
THE BIGGER TREND
Nanyang Technological University Singapore, Agency for Science, Technology and Research, and NHG recently launched another initiative to aid biomedical technology innovation. The organisations launched the SG$15 million ($10.7 million) incubator called co11ab in Health City Novena at NTU Singapores Lee Kong Chian School of Medicine. Geared to be fully operational in the initial quarter of 2023, co11ab provides startups with usage of industry expertise, mentorship, and funding support to build up their ideas and concepts into products.